Document:

EXHIBIT
4.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

ROCKETFUEL
BLOCKCHAIN, INC.

 

	Warrant
    Shares: _______	Issue
    Date: September __, 2022
	Warrant
    No.: _________	Initial
    Exercise Date: September __, 2022

 

THIS
COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the
“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m.
(New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for
and purchase from RocketFuel Blockchain, Inc., a Nevada corporation (the “Company”),
up to __________shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock,
par value $0.001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), dated September 8, 2022, among the Company and the Purchaser’s
signatory thereto.

 

Section
2. Exercise.

 

(a) Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of
Exercise”). Within two (2) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn
on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice
of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.

 

 

1     
 Insert the date that is the five-year anniversary of the Issue Date, provided that, if such date is not a Trading Day, insert
the immediately following Trading Day.

 

    	 

    	 

    

 

(b) Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $0.2065, subject to adjustment hereunder (the “Exercise
Price”).

 

(c) Cashless
Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

	 	(A)	=	 as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular
trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
	 	 	 	 
	 	(B)	=	 the Exercise Price of this Warrant, as adjusted hereunder;
and
	 	 	 	 
	 	(X)	=	 the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.

 

    	2

    	 

    

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading
on a Trading Market and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (c) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the
Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.

 

“VWAP”
means, for any date, the price determined by the first
of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City
time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices for the Common Stock are then
reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price per share of the Common Stock so reported, or (c) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).

 

(d) Mechanics
of Exercise.

 

(i) Delivery
of Warrant Shares Upon Exercise. Following delivery of the Notice of Exercise, the Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if
the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant is exercised on a cashless basis and the Warrant
Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical
delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the later of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price (other than in the case of a cashless exercise price) and Notice of Exercise
to the Company (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
is received by the Warrant Share Delivery Date. The Company agrees to maintain a transfer agent that is a participant in the FAST program
so long as this Warrant remains outstanding and exercisable. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the
date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered
or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as
this Warrant remains outstanding and exercisable.

 

    	3

    	 

    

 

(ii) Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.

 

(iii) Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

(iv) Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.

 

    	4

    	 

    

 

(v) No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.

 

(vi) Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer
Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

(vii) Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

 

(e) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be the Beneficial Ownership Blocker percentage shown on the signature page to the Holder’s Purchase Agreement multiplied
by the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not
be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and
implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.

 

    	5

    	 

    

 

Section
3. Certain Adjustments.

 

(a) Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 1(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re classification.

 

(b) Subsequent
Equity Sales. If the Company at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or sell or
grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition)
any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in effect (such lower
price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being
understood and agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation
of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options
or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective
price per share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price
on such date of the Dilutive Issuance at such effective price), then simultaneously with the consummation of each Dilutive Issuance the
Exercise Price shall be reduced and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall
be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price,
shall be equal to the aggregate Exercise Price prior to such adjustment. Such adjustment shall be made whenever such Common Stock or
Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section 3(b)
in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance
Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section
3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base
Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. Notwithstanding anything
herein to the contrary, this Section 3(b) shall terminate and be of no further force or effect after the later of (i) the one year anniversary
of the Initial Exercise Date, and (ii) the earlier of (A) six months after the effective date of the registration statement registering
all of the shares of Common Stock required to be registered pursuant to the Registration Rights Agreement (in the event multiple registration
statements are required to register all such shares, then this provision shall refer to the last of such registration statements to become
effective), and (B) six months after the date that all of the Warrant Shares and shares of Common Stock issued or issuable under the
Debentures are freely tradable under Rule 144 without the requirement to be in compliance with the current public information requirements
thereunder.

 

    	6

    	 

    

 

(c) Subsequent
Rights Offerings. In addition to any adjustments pursuant to Section 1(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all of the record holders
of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held
the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights; provided, however, that to the extent that
the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation.

 

(d) Pro
Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however,
that to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).

 

    	7

    	 

    

 

(e) Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities,
cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
“Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this
Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that (i) if the
Fundamental Transaction is not within the Company’s control, including not approved by the Company’s Board of Directors,
Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental
Transaction, the same type or form of consideration (and in the same proportion) for the purchase of this Warrant, at the value per share
of Common Stock in the Fundamental Transaction for each Warrant Share underlying the unexercised portion of this Warrant, that is being
offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration
be in the form of cash, shares or any combination thereof, or whether the holders of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; and (ii) for purposes of clarification, Holder
shall not be required to exercise the Warrant or pay the exercise price thereof in order to receive such consideration. “Black
Scholes Value” means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the “OV”
function on Bloomberg, L.P. (“Bloomberg”) determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility
equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing
a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered
in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater
of (x) the last VWAP immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior
to the consummation of such Fundamental Transaction, (D) a zero cost of borrow and (E) a remaining option time equal to the time between
the date of the public announcement of the applicable Fundamental Transaction and the Termination Date. The payment of the Black Scholes
Value will be made by wire transfer of immediately available funds within five Business Days of the Holder’s election (or, if later,
on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which
the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company
under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(f) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if
such Successor Entity had been named as the Company herein.

 

    	8

    	 

    

 

(f) Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

(g) Notice
to Holder.

 

(i) Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver
to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

(ii) Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email
address as it shall appear upon the Warrant Register of the Company, at least five (5) calendar days prior to the applicable record or
effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall not later than the delivery of such
notice file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this
Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may
otherwise be expressly set forth herein.

 

    	9

    	 

    

 

Section
4. Transfer of Warrant.

 

(a) Transferability.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.01 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

(b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c) Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

 

    	10

    	 

    

 

(d) Transfer
Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.07 of the Purchase Agreement.

 

(e) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.

 

Section
5. Miscellaneous.

 

(a) No
Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a “cashless exercise,” and to receive
the cash payments contemplated pursuant to Section 2(d)(i) and Section 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.

 

(b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

(c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

 

(d) Authorized
Shares.

 

(i) The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

    	11

    	 

    

 

(ii) Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but
will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

(iii) Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

(e) Jurisdiction.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with Section 5.09 of the Purchase Agreement.

 

(f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

(g) Nonwaiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall
operate as a waiver of such right or otherwise prejudice such party’s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if either the Holder or the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the other party, the party who failed to comply with the Warrant shall pay to the materially damaged party
such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees,
including those of appellate proceedings, incurred by the materially damaged party in collecting any amounts due pursuant hereto or in
otherwise enforcing any of its rights, powers or remedies hereunder.

 

    	12

    	 

    

 

(h) Notices.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.

 

(i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.

 

(j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

(k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.

 

(l) Amendment.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.

 

(Signature
Page Follows)

 

    	13

    	 

    

 

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	ROCKETFUEL
  BLOCKCHAIN, INC.
	 	 	 
	 	By:	                
	 	Name:	 
	 	Title:	 

 

    	14

    	 

    

 

NOTICE
OF EXERCISE

 

TO: ROCKETFUEL
BLOCKCHAIN, INC.

 

(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment
shall take the form of (check applicable box):

 

[
] in lawful money of the United States; or

 

[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in Section 2(c).

 

(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited
Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of
1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: __________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: ___________________________

 

Name
of Authorized Signatory: ______________________________________________

 

Title
of Authorized Signatory: _______________________________________________

 

Date:
___________________________________________________________________

 

    	 

    	 

    

 

EXHIBIT
B

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to:

 

	Name:	 
	 	(Please
    Print)
	Address:	 
	 

     

    Phone
    Number:

     

    Email
    Address:
	(Please
    Print)

     

    ______________________________________

     

    ______________________________________

	Dated:
    _______________ __, ______	 
	Holder’s
    Signature:________________________ 	 
	Holder’s
    Address:_________________________EXHIBIT
4.2

 

PRIVATE
AND CONFIDENTIAL

DO
NOT DISTRIBUTE OR DISCLOSE

 

GENERAL
NOTICE

 

THIS
INSTRUMENT AND THE TOKENS ARE NOT BEING OFFERED, SOLD OR ISSUED AND HAVE NOT BEEN REGISTERED OR QUALIFIED IN ANY STATE OR OTHER JURISDICTION
IN THE WORLD, WHERE THE OFFER, OR SALE OR ISSUANCE THEREOF IS NOT PERMITTED. THIS INSTRUMENT IS BEING OFFERED, SOLD, AND ISSUED ONLY
IN JURISDICTIONS WHERE SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED, INCLUDING PURSUANT TO APPLICABLE EXEMPTIONS THAT LIMIT THE
PURCHASERS WHO ARE ELIGIBLE TO PURCHASE THIS INSTRUMENT AND THAT RESTRICT ITS RESALE. NO GOVERNMENTAL AUTHORITY HAS REVIEWED THIS INSTRUMENT
OR ANY RELATED DOCUMENTS OR COMMUNICATIONS OR CONFIRMED THE ACCURACY, TRUTHFULNESS, OR COMPLETENESS OF THIS DOCUMENT OR ANY RELATED DOCUMENTS
OR COMMUNICATIONS. ANY REPRESENTATION TO THE CONTRARY IS ILLEGAL. YOU ARE REQUIRED TO INFORM YOURSELF ABOUT, AND TO OBSERVE ANY RESTRICTIONS
RELATING TO, THIS INSTRUMENT, THE TOKENS, AND ANY RELATED DOCUMENTS AND COMMUNICATIONS IN YOUR JURISDICTION. NEITHER THIS INSTRUMENT
NOR THE TOKENS MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER APPLICABLE LAWS.

 

NOTICE
TO RESIDENTS OF THE UNITED STATES

 

THIS
DOCUMENT IS NOT BEING OFFERED OR DISTRIBUTED TO ANY RESIDENT OF, OR ANY PERSON LOCATED OR DOMICILED IN THE UNITED STATES, OTHER THAN
TO CERTAIN ACCREDITED INVESTOR AS DEFINED IN RULE 501 UNDER THE U.S. SECURITIES ACT. THE INSTRUMENTS BEING OFFERED HAVE NOT BEEN REGISTERED
UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY U.S. STATES.
THE INSTRUMENTS BEING OFFERED ARE RESTRICTED SECURITIES UNDER THE U.S. SECURITIES ACT AND MAY NOT BE OFFERED, SOLD, RESOLD OR OTHERWISE
TRANSFERRED IN THE UNITED STATES OR FOR THE ACCOUNT OR BENEFIT OF U.S. PERSONS (AS DEFINED IN RULE 902 OF REGULATION S UNDER THE U.S.
SECURITIES ACT) DURING THE APPLICABLE DISTRIBUTION COMPLIANCE PERIOD WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN
OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE U.S. SECURITIES ACT. HEDGING
TRANSACTIONS WITH REGARD TO THE INSTRUMENTS SHALL ALSO BE PROHIBITED UNLESS IN COMPLIANCE WITH THE U.S. SECURITIES ACT. THIS INSTRUMENT
HAS NOT BEEN APPROVED FOR TRADING BY THE U.S. COMMODITY FUTURES TRADING COMMISSION UNDER THE U.S. COMMODITY EXCHANGE ACT OF 1936, AS
AMENDED.

 

NOTICE
TO RESIDENTS OF CANADA

 

UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS INSTRUMENT MUST NOT TRADE THE INSTRUMENT BEFORE THE DATE THAT THE ISSUER BECOMES
A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY.

 

    	 

    	 

    

 

ROCKETFUEL
BVI LTD.

 

Pre-Launch
Token Sale Agreement [PIPE]

 

THIS
PRE-LAUNCH TOKEN SALE AGREEMENT (this “Agreement”) is made on or about September __, 2022 (the “Agreement
Date”), by and between [                       
] (the “Purchaser”) and RocketFuel BVI, Ltd., a British Virgin Islands (“BVI”) business company
incorporated under the laws of BVI (the “Company”), in exchange for the payment by the Purchaser of the Purchase Amount
(as defined below), subject to the terms and conditions set forth below.

 

1.
Events.

 

(a)
Token Distribution. At the Closing, subject to Sections 1(b) and 1(c), the Company will deliver to the Purchaser the number
of Purchaser Tokens set forth on the signature pages hereto, according to the following lockup schedule: one fourth (25%) of the Tokens
will be delivered to the Purchaser six months from the Effective Date (as defined below) and the remaining three fourths (75%) will be
delivered to the Purchaser ratably in three (3) equal quarterly installments every three (3) months thereafter on the same day of the
month as the Effective Date (or if there is no corresponding day, the last day of the month).

 

In
connection with the issuance and delivery of Tokens by the Company to the Purchaser pursuant to this Section 1(a), the Purchaser will
execute and deliver to the Company all documents related to the use of the Tokens on the Network (the “Token Documents”)
so long as terms of such Token Documents are substantially the same as those published by the Company for general use of the Tokens on
the Network (the “Terms of Use”). Such Token Documents will supersede the disclosures, terms and conditions previously
provided, made available to or discussed with the Purchaser, if any, except that the Token delivery terms shall be as set forth herein.
The Purchaser acknowledges that the Terms of Use are subject to change on an ongoing basis in the sole and absolute discretion of the
Company as and to the extent the Company deems necessary or advisable. In addition, the Tokens issued pursuant to this Section 1(a) shall
not be issued if (i) the representations and warranties of Token purchasers set forth in the Token Documents are not true with respect
to the Purchaser at the time of the Token delivery, or (ii) the Purchaser is otherwise not eligible to receive Tokens under the Token
Documents or Terms of Use. In the event the Purchaser is not eligible to receive Tokens under the Token Documents or Terms of Use, the
Company will, unless otherwise required by law, pay to the Purchaser (as a general unsecured creditor) an amount equal to (i) the Purchase
Amount minus (ii) the product of the Price Per Token multiplied by the number of Tokens already delivered to Purchaser at the time of
payment pursuant to this sentence (when calculated, the “Refund Amount”).

 

(b)
Required Withdrawal. The Company shall be authorized to terminate this Agreement and refund the Refund Amount if: (i) the
Company’s external legal counsel advises that this Agreement would be or is reasonably likely to be in violation of applicable
securities laws or regulations, or (ii) this Agreement causes or would be reasonably likely to cause, extraordinary expense, substantial
additional obligations or a material adverse effect on the Company, any of its Affiliates, or other Purchasers. Following the execution
of this Agreement, to the extent necessary and required by law, the Company may take additional steps or request reasonable additional
information to verify the accuracy of the representations and warranties made in Exhibit A. In the event that the Company, in its sole
but reasonable discretion, is unable to reasonably verify the accuracy of such information, the Company shall be authorized to terminate
this Agreement and refund the Refund Amount.

 

    	- 2 -

    	 

    

 

(c)
Termination. This Agreement will expire and terminate upon the delivery of the Tokens to the Purchaser pursuant to Section
1(a) or the Company’s decision to terminate this Agreement pursuant to Section 1(b). In addition, this Agreement may be terminated
by mutual written consent of the parties to this Agreement. Upon termination of this Agreement pursuant to this Section 1(d), unless
otherwise the Company and Purchaser negotiate in good faith and mutually agree upon a substitute valid and enforceable resolution or
agreement, and unless otherwise required by law, the Company shall within ten (10) days upon the termination of this Agreement pay an
amount equal to the Refund Amount in U.S. Dollars to a bank account designated by the Purchaser.

 

2.
Definitions.

 

“Affiliate”
means, with respect to any party, a Person that controls, is controlled by or under common control with such party; where “control”
means, with respect to any Person, ownership by another Person of more than 50% of such Person’s voting securities.

 

“Application”
means the primary software application developed by the Company in which the Company intends the Tokens to be used.

 

“Articles
of Association” means the Company’s Memorandum and Articles of Association, dated May 12, as may be amended or restated
from time to time.

 

“Blockchain”
means the primary blockchain protocol, whether existing or created by the Company, as designated by the Company in its sole discretion,
on which initial generation and transfers of the Tokens are recorded.

 

“Closing”
has the meaning set forth in the SPA.

 

“Disqualified
Jurisdiction” means the United States of America (including its territories), Canada, People’s Republic of China, and
any other jurisdiction where the investment, purchase, and/or use of the Tokens is unavailable or unlawful.

 

“Dissolution
Event” means (i) a voluntary termination of operations of the Company on a permanent basis; (ii) a general assignment for the
benefit of the Company’s creditors; or (iii) any other liquidation, dissolution or winding up of the Company (excluding
a liquidity event), whether voluntary or involuntary.

 

“Effective
Date” means the date of the closing of the offering of Tokens under this Agreement and all other Pre-Launch Token Sale Agreements
and the beginning of the applicable distribution compliance period as defined in Rule 902(f) of Regulation S (“Reg S”)
under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”).

 

“Person”
means individual or legal entity or person, including a government or political subdivision or an agency or instrumentality thereof.

 

“Price
Per Token” is equal to $0.0001.

 

“Pre-Launch
Token Sale Agreement” means an instrument for the purchase of Tokens, similar in form and content to this Agreement, sold by
the Company.

 

“Purchase
Amount” means the number of Tokens purchased by the Purchaser, as indicated on the signature pages hereto, multiplied by the
Price per Token.

 

    	- 3 -

    	 

    

 

“Token(s)”
means the cryptographic, blockchain-based tokens that are currently referred to as “RKFL” tokens in the Company’s current
Token white paper or other Token marketing materials. The term “Tokens” shall not refer to any cryptographic, blockchain-based
tokens that the Company determines, in consultation with a nationally recognized U.S. law firm, would otherwise not be treated as securities
under U.S. securities laws, but for the fact such tokens have been offered or sold to investors in a capital raising transaction. For
example, non-fungible tokens, stablecoins and fixed price tokens would generally not be the type of Tokens covered by this Agreement.

 

“Token
Supply” means the maximum total number of Tokens that could ever be generated on the Network.

 

3.
Currency Treatment. In the event that the Purchase Amount (or any portion thereof) is paid in any currency or property, including
digital currencies, other than U.S. dollars, the value of the Purchase Amount or Refund Amount shall, if it is necessary to determine
an equivalent amount in U.S. dollars, be deemed to be, at the Company’s election (i) the U.S. dollar equivalent of such currency
or property as of the date and time this Agreement is executed by the Company as published on such exchange or exchanges as shall be
determined in the sole discretion of the Company, or (ii) the U.S. dollar value, net of any exchange fees or costs, actually received
by the Company upon exchange of such currency or property into U.S. dollars (but only if the Company actually converts the Purchase Amount
into U.S. dollars as promptly as practicable following the Company’s receipt of the Purchase Amount).

 

4.
Company Representations.

 

(a)
The Company is a BVI business company duly incorporated, validly existing and in good standing under the laws of the British Virgin Islands
and has the power to own, lease, and operate its properties and carry on its business as now conducted.

 

(b)
The execution, delivery and performance by the Company of this Agreement is within the power of the Company and has been duly authorized
by all necessary actions on the part of the Company. This Agreement constitutes a legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application
relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.

 

(c)
The performance and consummation of the transactions contemplated by this Agreement do not and will not: (i) to the knowledge of the
Company, violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any
material indenture or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition
of any lien upon any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license
or authorization applicable to the Company, its business or operations.

 

(d)
No consents or approvals are required in connection with the performance of this Agreement, other than: (i) the Company’s corporate
approvals; (ii) to the knowledge of the Company, any qualifications or filings under applicable securities laws; and (iii) necessary
corporate approvals for the authorization of Tokens to be delivered pursuant to Section 1(a).

 

5.
Purchaser Representations

 

(a)
Purchaser makes the representations and warrants set forth in Exhibit A.

 

    	- 4 -

    	 

    

 

6.
Purchaser Covenants 

 

(a)
Purchaser shall immediately notify Company (i) if any representation or warranty of Purchaser in this Agreement becomes untrue, or if
any change in facts or circumstances renders any representation or warranty materially misleading, or (ii) if any other information,
in any form, provided by Purchaser to Company or an affiliate thereof in connection with Purchaser’s proposed investment shall
become untrue, or if any change in facts or circumstances renders any representation or warranty materially misleading, in each case
prior to Purchaser’s receipt of any Token.

 

(b)
The Purchaser hereby consents to the Company transferring the Purchaser’s personal data to any of its Affiliates for processing
and to recipients in countries which do not provide the same level of data protection as the British Virgin Islands. The Company and
each of its Affiliates may use the Purchaser’s information for any purpose they determine including, without limitation, for administration,
marketing, customer services, crime (including tax evasion) prevention and detection, anti-money laundering, due diligence and verification
of identity purposes. The Company and each of its Affiliates may further disclose the Purchaser’s information to any of their respective
service providers, agents, relevant custodians or similar third parties for any reason and such persons may keep the Purchaser’s
information for any period of time permitted by applicable law. The Purchaser does hereby consent to the Company and any of its Affiliates
disclosing any of the Purchaser’s information which they hold to any governmental authority or prosecuting authority for any reason
and without notice to the Purchaser. The Purchaser hereby acknowledges and agrees to hold the Company and each of its Affiliates harmless
in respect of any disclosure of information by such persons in accordance with this Agreement. For the avoidance of any doubt, the Company
and each of its Affiliates shall not be liable to the Purchaser or any other person for any loss, damage or expense incurred directly
or indirectly as a result of such disclosure.

 

(c)
Upon request, Purchaser agrees to provide any additional documentation that Company may reasonably request to (i) verify Purchaser is
not a “U.S. Person”, or (ii) confirm that Purchaser meets any applicable minimum financial suitability standards, or (iii)
ensure compliance with all applicable laws and regulations concerning money laundering and similar activities, including but not limited
to any information necessary to verify the identity of Purchaser and the source of any funds used to purchase the interests.

 

7.
Indemnification 

 

Purchaser
agrees to indemnify and hold the Company and its Affiliates and each of its or their respective officers, directors, agents, joint venturers,
employees and representatives (each, a “Company Party”), harmless from any third-party claim or third-party demand (including
reasonable and documented attorneys’ fees and any fines, fees or penalties imposed by any regulatory authority) arising out of
or related to Purchaser’s (i) breach of this Agreement, and (ii) gross negligence, fraud or willful misconduct, except where such
claim directly results from the gross negligence, fraud or willful misconduct of the Company. The remedies provided in this Section 7
shall be cumulative and shall not preclude the assertion by any Company Party of any other rights or the seeking of any other remedies
against the Purchaser. This indemnification shall survive any disposition of the Purchaser’s Tokens.

 

    	- 5 -

    	 

    

 

8.
Disclaimer; Limitation of Liability 

 

(a)
The Company shall not be liable or responsible to the Purchaser, nor be deemed to have defaulted under or breached this Agreement, in
each case, for any failure or delay in fulfilling or performing its obligations under Section 1, if and to the extent that such failure
or delay is caused by, or results from, acts beyond the affected party’s reasonable control, including, without limitation: (i)
acts of God; (ii) flood, fire, earthquake or explosion; (iii) war, invasion, hostilities (whether war is declared or not), terrorist
threats or acts, or other civil unrest; (iv) applicable law or regulations; (v) action by any governmental authority; (vi) cyber-attacks,
malware attacks, denial of service attacks, consensus-based attacks, Sybil attacks, smurfing, spoofing and similar events; or (vii) technological
changes not within the control of the Company (including changes imposed by platforms or networks related to the Tokens and the Network).

 

(b)
THE COMPANY MAKES NO WARRANTY WHATSOEVER WITH RESPECT TO THE TOKENS, INCLUDING, WITHOUT LIMITATION, ANY (i) WARRANTY OF MERCHANTABILITY;
(ii) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; WARRANTY OF TITLE; OR (iii) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY
RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE, OR OTHERWISE. EXCEPT AS EXPRESSLY
SET FORTH HEREIN, PURCHASER ACKNOWLEDGES THAT IT HAS NOT RELIED UPON ANY REPRESENTATION OR WARRANTY MADE BY THE COMPANY, OR ANY OTHER
PERSON ON THE COMPANY’S BEHALF.

 

(c)
To the fullest extent permitted by applicable law (i) in no event will any Company Party be liable for any indirect, special, incidental,
consequential, or exemplary damages of any kind (including, but not limited to, where related to loss of revenue, income or profits,
loss of use or data, or damages for business interruption) arising out of or in any way related to this Agreement, the Tokens or the
use of the Protocol, regardless of the form of action, whether based in contract, tort or any other legal or equitable claim (even if
the party has been advised of the possibility of such damages and regardless of whether such damages were foreseeable); and (ii) in no
event will the aggregate liability of the Company Parties, whether in contract, tort or other legal or equitable claim, arising out of
or relating to this Agreement, the Tokens or the use of the Protocol exceed the amount the Purchaser pays to the Company hereunder.

 

9.
Assignment.

 

(a)
Subject to Section 9(b), the Purchaser shall not, by operation of law or otherwise, directly or indirectly (and shall not agree to) assign
the benefit of this Agreement (in whole or in part) without the prior written consent of the Company. Subject to Section 9(c), the Company
shall not, by operation of law or otherwise, directly or indirectly (and shall not agree to) assign this Agreement nor the rights and/or
obligations contained herein, without the prior written consent of the Purchaser.

 

(b)
The Purchaser shall be entitled, without the consent of the Company, after having given no less than three (3) business days’ prior
written notice to the Company, to assign the benefit of this Agreement (in whole or in part) any Tokens (or economic interest in any
Token) or transfer any or all its obligations and liabilities under this Agreement to any other entity that directly or indirectly, controls,
is controlled by or is under common control with the Purchaser, including, without limitation, any general partner, managing member,
officer or director of the Purchaser, or any venture capital fund now or hereafter existing which is controlled by one or more general
partners or managing members of, or shares the same management company with, the Purchaser (an “Assignee”), provided
that the Assignee: (i) undertakes in writing to the Company to be bound by the Purchaser’s obligations and liabilities under this
Agreement; (ii) warrants in writing to the Company that each of the Purchaser’s representations set forth in Exhibit A and elsewhere
in this Agreement is true, accurate and not misleading as at the date of the assignment or transfer with respect to itself (as if each
reference to the Purchaser is construed as a reference to the Assignee); and (iii) delivers such other documents to the Company relating
to this Agreement as the Company may reasonably request.

 

    	- 6 -

    	 

    

 

(c)
The Company may assign this Agreement in whole, without the consent of the Purchaser, (i) in connection with a reincorporation to change
the Company’s domicile or a transfer by way of continuation of the company to another jurisdiction or (ii) to a direct or indirect
subsidiary or affiliate of the Company, a Designated Foundation, or a direct or indirect subsidiary or affiliate of a Designated Foundation.

 

10.
Confidentiality

 

(a)
Definition of Confidential Information. “Confidential Information” shall mean any non-public information of a party
that includes, without limitation, ideas, processes, computer programs, materials, methods, data, sources of supplies, technology, research,
know-how, improvements, discoveries, developments, designs, inventions, techniques, marketing plans, forecasts, new product information,
unpublished financial information, budgets, business plans, projections, prices, costs, customer lists, and marketing information. Confidential
Information shall not include information that: (i) is or subsequently becomes publicly available without Receiving Party’s breach
of any obligation owed to Disclosing Party; (ii) was known to Receiving Party prior to Disclosing Party’s disclosure of such information
to Receiving Party; (iii) became known to Receiving Party from a source other than Disclosing Party other than by the breach of an obligation
of confidentiality owed to Disclosing Party; or (iv) was independently developed by Receiving Party without reference to information
disclosed by Disclosing Party, as evidenced by contemporaneous documentation.

 

(b)
Nonuse and Nondisclosure Obligations. The parties acknowledge and agree that in the performance of this Agreement one party (the
“Disclosing Party”) may disclose or permit access to Confidential Information (as defined below) to the other party
(“Receiving Party”) pursuant to the terms of this Agreement. Confidential Information disclosed under this Agreement
shall be held in confidence by the Receiving Party and shall disclose to any third party except to such Receiving Party’s officers,
directors, agents, employees, consultants, contractors and professional advisors who need to know the Confidential Information for the
purpose of assisting in the performance of this Agreement and who are informed of, and agree to be bound by obligations of confidentiality
no less restrictive than those set forth herein, and will protect such Confidential Information from unauthorized use and disclosure.
The parties further agree that their obligation to hold Confidential Information in confidence shall begin on the Effective Date of this
Agreement and continue for two (2) years after termination of this Agreement. Each party will use the same degree of care to protect
the other party’s Confidential Information as it uses to protect its own Confidential Information, but in no event shall such standard
be less than reasonable care. The parties further agree that their obligation to hold information in confidence shall apply regardless
of whether the Confidential Information is disclosed directly or indirectly, in writing, orally, or visually, that Receiving Party knows
or should know is confidential or proprietary. For the avoidance of doubt, the failure of Disclosing Party to mark any Confidential Information
as confidential, proprietary or otherwise shall not affect its status as Confidential Information hereunder.

 

(c)
Permitted Disclosures. Notwithstanding anything to contrary in this Section 10, Confidential Information may be disclosed by a
Receiving Party to the extent required by law, pursuant to duly authorized subpoena, court order or government authority, provided that
(a) the Receiving Party provides the Disclosing Party with prompt notice of such disclosure requirement or obligation as soon as reasonably
practicable and legally permissible under applicate laws to permit Disclosing Party to seek a protective order or other remedy appropriate
for protecting the Confidential Information from disclosure; and (b) the Receiving Party limits the release of the Confidential Information
to the greatest extent possible under the circumstances.

 

    	- 7 -

    	 

    

 

11.
Miscellaneous.

 

(a)
This Agreement is one of a series of Pre-Launch Token Sale Agreements being sold by the Company from time to time. Any provision of this
Agreement may be amended, waived or modified only upon the written consent of the Company and the purchasers of a majority in aggregate
purchase amount paid to the Company with respect to all outstanding Pre-Launch Token Sale Agreements at the time of such amendment, waiver
or modification.

 

(b)
This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes
all prior or contemporaneous disclosures, discussions, understandings and agreements, whether oral or written, between them relating
to the subject matter hereof. The Exhibits and Schedules identified in this Agreement are incorporated herein by reference and made a
part hereof as if set out in full herein.

 

(c)
Any notice required or permitted by this Agreement will be deemed sufficient (i) when delivered personally or by overnight courier or
sent by email to the relevant address listed on the signature page; or (ii) 48 hours after being deposited in the U.S. mail as certified
or registered mail with postage prepaid, addressed to the party to be notified at such party’s address listed on the signature
page, as subsequently modified by written notice.

 

(d)
In the event any one or more of the provisions of this Agreement is for any reason held to be invalid, illegal or unenforceable, in whole
or in part or in any respect, or in the event that any one or more of the provisions of this Agreement operate or would prospectively
operate to invalidate this Agreement, then and in any such event, only those such provision(s) will be deemed null and void and will
not affect any other provision of this Agreement, and the remaining provisions of this Agreement will remain operative and in full force
and effect and will not be affected, prejudiced, or disturbed thereby.

 

(e)
Both Company and Purchaser shall, and shall cause their respective affiliates to, execute and deliver such additional documents, instruments,
conveyances and assurances and take such further actions as may be reasonably requested by the other party to carry out the provisions
of this Agreement and give effect to the transactions contemplated by this Agreement, including, without limitation, to enable the Company
or the transactions contemplated by this Agreement to comply with applicable laws.

 

(f)
The Purchaser is not entitled, as a holder of this Agreement, to vote or receive dividends or be deemed the holder of shares of capital
of the Company for any purpose, nor will anything contained herein be construed to confer on the Purchaser, as such, any of the rights
of a shareholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any
meeting thereof, or to give or withhold consent to any corporate action or to receive notice of meetings, or to receive subscription
rights or otherwise until shares have been issued upon the terms described herein.

 

(g)
The respective rights of the parties set forth in Sections 4, 5, 6, 7 ,8, 9, 10, and 11 will survive the termination of this Agreement.

 

(h)
This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or the formation (including non-contractual
disputes or claims) shall be governed by and construed in accordance with the laws of the British Virgin Islands and shall be handled
under the jurisdiction of competent British Virgin Islands courts.

 

    	- 8 -

    	 

    

 

(i)
Each party to this Agreement acknowledges that Perkins Coie, LLP (“Perkins”), counsel to the Company, may have in
the past represented and may now or in the future represent one or more Purchasers or their affiliates in matters unrelated to the transactions
contemplated by this Agreement (this “Transaction”), including representation of such Purchasers or their affiliates
in matters of a similar nature to this Transaction. The applicable rules of professional conduct require that Perkins inform the parties
hereunder of this representation and obtain their informed consent. Perkins has served as counsel to the Company and has negotiated the
terms of this Transaction solely on behalf of the Company. The Company and each Purchaser hereby (a) acknowledge that they have had an
opportunity to ask for and have obtained information relevant to such representation, including disclosure of the reasonably foreseeable
adverse consequences of such representation; (b) acknowledge that with respect to this Transaction, Perkins has represented solely the
Company, and not any Purchaser or any shareholder, director or employee of the Company or any Purchaser; and (c) gives its informed consent
to Perkins’ representation of the Company in this Transaction despite any possible representation of the Purchaser(s) in other
matters as described above.

 

(j)
Neither party may use or disclose the other party’s name (directly or indirectly, explicitly or implicitly) in any manner that
indicates or suggests that there is or has been a relationship between the parties except with the affected party’s specific prior
written consent.

 

(k)
This Agreement may be executed in counterparts, each of which shall be deemed an original, but which taken together shall constitute
one and the same instrument. Any signature delivered by any form of electronic transmission shall be deemed an original and create a
valid and binding obligation of the executing party with the same force and effect as a physically delivered signature.

 

(Signature
page follows)

 

    	- 9 -

    	 

    

 

IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered as of the date first written above.

 

	 	ROCKETFUEL
    BVI LTD. 
	 	 	 
	 	By:	                
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	Email:	 

 

    	- 10 -

    	 

    

 

[SIGNATURE
PAGE TO TOKEN SALE AGREEMNT]

 

	 	PURCHASER:
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	Email:	                     

 

	 	Number
    of Tokens Purchased:	

 

    	- 11 -

    	 

    

 

EXHIBIT
A

 

TOKEN
PURCHASER ELIGIBILITY CRITERIA AND REPRESENTATIONS

 

General
Requirements:

 

The
Purchaser of the Tokens represents and warrants as follows:

 

		1.	Purchaser
                                            has full legal capacity, power and authority to execute and deliver this Agreement and to
                                            perform its obligations hereunder. This Agreement constitutes a legal, valid and binding
                                            obligation of the Purchaser, enforceable in accordance with its terms, except as limited
                                            by bankruptcy, insolvency or other laws of general application relating to or affecting the
                                            enforcement of creditors’ rights generally and general principles of equity.
	 	 	 
		2.	Purchaser
                                            is (i) not a “U.S. Person” as defined in Rule 902 of Reg S (a “U.S.
                                            Person”) or is not deemed to be a U.S. Person under Rule 902(k)(2) of Reg S; (ii)
                                            is not domiciled and has their principal place of business outside the United States as defined
                                            in Reg S (the “United States”); and (iii) is not acquiring Tokens for
                                            the account or benefit of a U.S. Person.
	 	 	 
		3.	Purchaser
                                            is acquiring the Tokens in an “offshore transaction” as defined by Rule
                                            902(h) of Reg S (i.e., the offer to sell the Tokens to Purchaser was not made to Purchaser
                                            in the United States and, at the time the transfer was completed, Purchaser was outside the
                                            United States).
	 	 	 
		4.	No
                                            “directed selling efforts” as defined in Rule 902(c) of Reg S were made
                                            in the United States (i.e., no marketing efforts were made to Purchaser in the United
                                            States) and in no event should this Agreement be construed as a prospectus, advertisement
                                            or a public offering of the Tokens in the United States. The Purchaser has not engaged and
                                            Purchaser will not engage or cause any third party to engage in any directed selling efforts
                                            (as defined in Reg S) in the United States with respect to the Tokens (or an interest in
                                            the Tokens or hedge transaction associated with the Tokens).
	 	 	 
		5.	Purchaser
                                            agrees to resell the Tokens only in accordance with the provisions of Reg S, pursuant to
                                            registration under the U.S. Securities Act, or pursuant to an available exemption from registration,
                                            and agrees that Purchaser shall not engage in hedging transactions with regard to the Tokens
                                            unless in compliance with the U.S. Securities Act. Purchaser has complied and will comply
                                            with the requirements of Reg S with respect to the Tokens (or an interest in the Tokens or
                                            hedge transaction associated with the Tokens).
	 	 	 
		6.	Purchaser
                                            will (i) conduct all of its activities under this Agreement outside the United States at
                                            all times and in accordance with applicable law and in satisfaction of Reg S; and (ii) ensure
                                            that any transaction involving a Token in which it is a party is an offshore transaction.
	 	 	 
		7.	Purchaser
                                            acknowledges and is aware that (i) the Company is not registered or licensed with any national,
                                            federal or state regulatory as an investment adviser, broker-dealer, or other form of entity
                                            regulated by a financial services regulator and accordingly Purchaser will not be afforded
                                            the full set of protections provided to the clients of such entities, including those under
                                            the U.S. Securities Act, the U.S. Securities Exchange Act of 1934, as amended, the Investment
                                            Advisers Act of 1940, as amended, and any similar national or state laws, (ii) this agreement
                                            and the Tokens have not been reviewed by, passed upon, or submitted to any securities regulatory
                                            authority or financial services regulator, and no such authority or regulator has expressed
                                            an opinion on this Agreement or the Tokens; and (ii) Tokens are not legal tender, are not
                                            backed by any government, and accounts and value balances associated with Tokens are not
                                            subject to deposit or investor protection, including protections of the U.S. Federal Deposit
                                            Insurance Corporation or the U.S. Securities Investor Protection Corporation.

 

    	- 12 -

    	 

    

 

		8.	Purchaser
                                            has complied and will comply with the transfer restrictions set forth below.
	 	 	 
		9.	Purchaser
                                            is not part of a plan or scheme on Purchaser’s part, or any of Purchasers’ affiliates
                                            or any person acting on Purchaser’s or Purchaser’s affiliates’ behalf to
                                            evade the registration requirements under the U.S. Securities Act.

 

Requirements
for Tokens received for Purchaser’s Own Account or by Subsequent Transferees:

 

The
following shall be non-exclusive eligibility requirements for the receipt of Tokens, and Purchaser represents and warrants with respect
to such Tokens as follows:

 

		1.	Purchaser
                                            has such knowledge and experience in financial and business matters such that Purchaser is
                                            capable of evaluating the merits and risks of the receipt of Tokens and by reason of Purchaser’s
                                            own business and financial experience has the capacity to protect its own interests regarding
                                            this Agreement and receipt of Tokens thereunder.
	 	 	 
		2.	Purchaser
                                            has the ability to bear the economic risk of their purchase or investment associated with
                                            Tokens, and Purchaser can hold the Tokens indefinitely and could afford a complete loss on
                                            the Tokens.
	 	 	 
		3.	Purchaser
                                            has obtained and reviewed all information about the Company and Tokens that Purchaser desires
                                            and which Purchaser feels is necessary to enable him to recognize and evaluate the merits
                                            and risks of their purchase or investment associated with the Tokens.
	 	 	 
		4.	Tokens
                                            are being acquired and will be held by Purchaser for personal investment or use, Purchaser
                                            is not a “distributor” (as such term is defined in Reg S) or a “dealer”
                                            (as such term is defined in the U.S. Securities Act), and Purchaser has no present intention
                                            of distributing the Tokens or any interest therein to others.

 

Transfer
Restrictions:

 

Purchaser
further represents and warrants as follows:

 

		1.	Purchaser
                                            acknowledges and is aware that in order to comply with Reg S as promulgated under the U.S.
                                            Securities Act, and other regulations, transfer of Tokens to U.S. Persons and persons of
                                            other jurisdictions are limited. In particular, pursuant to 17 C.F.R. § 230.903(3)(iii)(B)(2),
                                            the Purchaser agrees to resell the Tokens only in accordance with the provisions of Reg S,
                                            pursuant to registration under the U.S. Securities Act, or pursuant to an available exemption
                                            from registration, and agrees not to engage in hedging transactions with regard to the Tokens
                                            unless in compliance with the U.S. Securities Act. In addition, Purchaser’s Tokens
                                            may not be used, assigned, sold, traded, exchanged or otherwise transferred to any person
                                            in a restricted jurisdiction until such jurisdiction is no longer restricted. Additional
                                            transfer restrictions may continue to apply to Purchaser’s Tokens based on certain
                                            regulatory treatment in certain jurisdictions.

 

    	- 13 -

    	 

    

 

		2.	Purchaser
                                            acknowledges and is aware that there are substantial restrictions on the use and transferability
                                            of Tokens, and there will be no public market for the Tokens for U.S. Persons. The Tokens
                                            will not be registered under the U.S. Securities Act, or qualified under the securities law
                                            of any state in the United States and may not be offered or sold in the United States absent
                                            registration or an applicable exemption from the registration requirements of the U.S. Securities
                                            Act. This means that Purchaser and any other holders of Tokens may not transfer Tokens to
                                            any U.S. Person without registration or an exemption from registration under the U.S. Securities
                                            Act.
	 	 	 
		3.	Purchaser
                                            has been advised and fully comprehends that the Tokens are being treated by the Company in
                                            a manner consistent with securities under the U.S. Securities Act and that Purchaser acknowledges
                                            and agrees that Purchaser must treat the Tokens in the same manner for the foreseeable future
                                            and not take actions inconsistent with such treatment, and advise any subsequent transferee
                                            of the same, and that the Company is entering into this agreement in material reliance on
                                            Purchaser’s representations, warranties and covenants set out in this Agreement.
	 	 	 
		4.	Purchaser
                                            acknowledges and agrees that (i) the transfer restrictions applicable to Tokens set forth
                                            herein are binding upon subsequent transferees, except for transferees pursuant to an effective
                                            registration statement under the U.S. Securities Act, and that Purchaser shall inform any
                                            subsequent transferee of the transfer restrictions applicable to Tokens set forth in this
                                            Agreement and the rights and obligations applicable to a holder of the Token and the Company;
                                            (ii) any person to whom a subsequent transferee transfers will, in turn, be subject to applicable
                                            re-transfer restrictions depending upon the manner of any such transfer and therefore Purchaser
                                            will require each transferee to inform subsequent transferees of the transfer restrictions
                                            applicable to Tokens and require such subsequent transferees to do the same; and (iii) transfer
                                            restrictions applicable to Tokens are also applicable to interest in the Tokens or a hedge
                                            transaction associated with the Tokens and all references within this Agreement to transfer
                                            restrictions shall be construed accordingly.
	 	 	 
		5.	Purchaser
                                            shall not offer, sell, resell, pledge, hypothecate, transfer or otherwise dispose of any
                                            part or all of the Tokens (or an interest in the Tokens or hedge transaction associated with
                                            the Tokens) in the United States to or for the account or benefit of a U.S. Person except
                                            (i)(A) in an offshore transaction under Reg S (including, at a minimum, during the applicable
                                            distribution compliance period required under Category 3 of Rule 903 thereof), (B) pursuant
                                            to another available exemption from the registration requirements of the U.S. Securities
                                            Act, or (C) pursuant to an effective registration statement or its equivalent under the U.S.
                                            Securities Act that covers the Tokens; and (ii) in accordance with all applicable securities
                                            laws of the United States.
	 	 	 
		6.	Purchaser
                                            acknowledges and is aware that the Company shall refuse to permit any transfer of Tokens
                                            not made in accordance with the provisions of Reg S, pursuant to registration under the U.S.
                                            Securities Act or pursuant to an available exemption from registration, and that any transfer
                                            made in violation of the provisions applicable to transfer in this Agreement will be null
                                            and void and Company will not recognize any such attempted transfer.
	 	 	 
		7.	Purchaser
                                            acknowledges that prior to the expiration of the applicable distribution compliance period
                                            required under Category 3 of Rule 903 of Reg S, Purchaser and any other subsequent transferee
                                            of the Tokens may be required to provide to the Company or its agents certifications and
                                            other documentation relating to the non-U.S. Person status of any such transferee, and Purchaser
                                            agrees to so inform such transferee prior to any such proposed transfer.

 

    	- 14 -

    	 

    

 

		8.	The
                                            Company shall not register the transfer of any Tokens in violation of the restrictions set
                                            forth herein, and the Tokens will be deemed to bear the legend set forth below (in addition
                                            to any other legend required by U.S. or non-U.S. federal or state securities laws that may
                                            be applicable to the Tokens or provided in any other agreement with the Company):

 

THIS
OFFER AND SALE OF TOKENS HAS NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES
ACT”), OR UNDER THE SECURITIES LAWS OF ANY U.S. STATES AND THIS INSTRUMENT HAS BEEN ACQUIRED OUTSIDE THE UNITED STATES. THE
TOKENS ARE RESTRICTED SECURITIES AND MAY NOT BE OFFERED, SOLD, RESOLD OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR FOR THE ACCOUNT
OR BENEFIT OF U.S. PERSONS (AS DEFINED IN RULE 902 OF REGULATION S UNDER THE U.S. SECURITIES ACT) DURING THE APPLICABLE DISTRIBUTION
COMPLIANCE PERIOD WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE U.S. SECURITIES ACT. WARRANTS ASSOCIATED WITH THE TOKENS (IF ANY), AND ANY INSTRUMENT
THAT MAY BE ISSUED UNDER SUCH WARRANTS, HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND MAY NOT BE EXERCISED BY OR ON BEHALF
OF ANY U.S. PERSON UNLESS REGISTERED UNDER THE U.S. SECURITIES ACT OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE AND COMPLIED WITH TO
THE SATISFACTION OF THE COMPANY. HEDGING TRANSACTIONS WITH REGARD TO THE TOKENS SHALL ALSO BE PROHIBITED UNLESS IN COMPLIANCE WITH THE
U.S. SECURITIES ACT. THIS INSTRUMENT HAS NOT BEEN APPROVED FOR TRADING BY THE U.S. COMMODITY FUTURES TRADING COMMISSION UNDER THE U.S.
COMMODITY EXCHANGE ACT OF 1936, AS AMENDED.

 

BY
ITS ACQUISITION HEREOF, THE HOLDER (I) REPRESENTS THAT IT IS NOT A U.S. PERSON AND IS ACQUIRING THE TOKEN IN AN OFFSHORE TRANSACTION,
(II) AGREES THAT IT WILL NOT RESELL OR OTHERWISE TRANSFER THE TOKEN EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE U.S. SECURITIES ACT, (B) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S OR (C) PURSUANT TO ANY OTHER EXEMPTION FROM REGISTRATION
UNDER THE U.S. SECURITIES ACT (IF AVAILABLE), AND (III) AGREES THAT IT WILL GIVE TO EACH PERSON TO WHOM THE TOKEN IS TRANSFERRED A NOTICE
SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. AS USED HEREIN, THE TERMS “OFFSHORE TRANSACTION,” “UNITED STATES”
AND “U.S. PERSON” HAVE THE MEANINGS GIVEN TO THEM BY REGULATION S UNDER THE U.S. SECURITIES ACT.

 

CONSISTENT
WITH THE COMPANY’S TREATMENT OF THE TOKEN AS A SECURITY UNDER THE U.S. SECURITIES ACT FOR THE FORESEEABLE FUTURE THIS LEGEND HAS
BEEN INCLUDED TO COMPLY WITH REGULATION S. IT SHOULD NOT OTHERWISE BE CONSTRUED AS OR RELIED UPON AS AN ACKNOWLEDGMENT BY THE COMPANY
OF THE LEGAL OR REGULATORY CHARACTERIZATION OF THE TOKEN UNDER APPLICABLE LAWS.

 

    	- 15 -

    	 

    

 

Other
Representations:

 

Purchaser
further represents and warrants as follows:

 

		1.	The
                                            Purchaser has been advised that this Agreement has not been approved for trading by the CFTC.
                                            The Purchaser represents that it is not purchasing this Agreement on the basis that it is
                                            a contract of sale of a commodity for future delivery (or option on such a contract), a swap
                                            or any other instrument subject to the CEA.
	 	 	 
		2.	The
                                            Purchaser understands that the Company is not licensed as a money transmitter (“MT”)
                                            or a money services business (“MSB”). If the Company was deemed to be
                                            an MT and/or MSB, it would be subject to significant additional regulation. This could lead
                                            to significant changes with respect to the Network, how the Tokens are structured, how they
                                            are purchased and sold, and other issues, and would greatly increase the Company’s
                                            costs in creating and facilitating transactions in the Tokens. It could lead to the termination
                                            of the Tokens. Further, a regulator could take action against the Company if it views the
                                            Tokens and the Network as a violation of existing law. Any of these outcomes would negatively
                                            affect the value of the Tokens and/or could cause the Company to cease operations.
	 	 	 
		3.	The
                                            Purchaser understands that the Tokens are non-refundable and cannot be exchanged for cash
                                            (or its equivalent value in any other virtual currency) or any payment obligation from the
                                            Company or any Affiliates.
	 	 	 
		4.	The
                                            Purchaser is not registered with the U.S. Securities and Exchange Commission as a broker-dealer,
                                            alternative trading system or exchange, and is not a member of the U.S. Financial Industry
                                            Regulatory Authority (“FINRA”) nor is required to be registered with the
                                            U.S. Securities and Exchange Commission or is subject to the rules of FINRA.
	 	 	 
		5.	Purchaser
                                            and their Affiliates shall comply at all times with all laws, statutes and regulations relating
                                            to anti-money laundering, countering the financing of terrorism, sanctions, anti-bribery
                                            and anti-corruption under all laws applicable to it or them (as the case may be).
	 	 	 
		6.	Purchaser
                                            has read and understands the risk factors attached hereto as Exhibit B of the
                                            Agreement (the “Risk Factors”).
	 	 	 
		7.	The
                                            Purchaser has not relied on any representations or warranties made by the Company outside
                                            of this Agreement, including, but not limited to, conversations of any kind, whether through
                                            oral or electronic communication. The Purchaser represents that it has adequate information
                                            on which to base its decision to purchase Tokens through this Agreement. The Purchaser acknowledges
                                            that such potential changes may be significant and understands that the Token Documents and
                                            Terms of Use shall be determined by the Company in its sole and absolute discretion and will
                                            be binding on the Purchaser regardless of the extent, nature or impact of such changes.
	 	 	 
		8.	The
                                            Purchaser understands that no federal or state agency or any other governmental authority
                                            has passed on or made any recommendation or endorsement of this Agreement or the Tokens or
                                            the fairness or suitability of this investment, nor has any governmental authority passed
                                            upon or endorsed the merits of this offering. The Purchaser understands that the Company
                                            is not subject to supervision or regulation by any governmental or regulatory authority in
                                            the BVI or elsewhere.

 

    	- 16 -

    	 

    

 

		9.	The
                                            Purchaser’s entry into this Agreement complies with applicable laws and regulations
                                            in the Purchaser’s jurisdiction.
	 	 	 
		10.	The
                                            Purchaser understands and acknowledges that title to, and risk of loss of, Tokens it receives
                                            from the Company passes from the Company to Purchaser in the British Virgin Islands.
	 	 	 
		11.	The
                                            Purchaser understands that the Purchaser bears sole responsibility for any tax obligations
                                            of the Purchaser as a result of the matters and transactions that are the subject of this
                                            Agreement, and any future acquisition, ownership, use, sale or other disposition of Tokens
                                            held by the Purchaser. To the extent permitted by law, the Purchaser agrees to indemnify,
                                            defend and hold the Company or any of its affiliates, employees or agents (including developers,
                                            auditors, contractors or founders) harmless for any claim, liability, assessment or penalty
                                            with respect to any taxes (other than any net income taxes of the Company that result from
                                            the delivery of Tokens to the Purchaser pursuant to this Agreement) associated with or arising
                                            from the Purchaser’s purchase of Tokens hereunder, or the use or ownership of Tokens.
	 	 	 
		12.	Unless
                                            the Purchaser is an accredited investor within the meaning of Rule 501 under the U.S. Securities
                                            Act, the Purchaser is not a resident of and is not domiciled in, any Disqualified Jurisdiction
                                            or purchasing the Tokens from a location in any Disqualified Jurisdiction, and the Purchaser
                                            is not a natural person who is a resident of, or physically located in, the British Virgin
                                            Islands.
	 	 	 
		13.	The
                                            Purchaser is not a “Prohibited Person”, meaning that the Purchaser is
                                            not (i) a citizen or resident of a geographic area in which use of cryptographic tokens is
                                            prohibited by applicable law, decree, regulation, treaty, or administrative act; (ii) a citizen
                                            or resident of, or located in, a geographic area that is subject to U.S. or other applicable
                                            sanctions or embargoes; or (iii) an individual, or an individual employed by or associated
                                            with an entity, that is identified on the U.S. Department of Commerce’s Denied Persons
                                            or Entity List, or the U.S. Department of Treasury’s Specially Designated Nationals
                                            or Blocked Persons Lists, or the U.S. Department of State’s Debarred Parties List or
                                            the sanctions lists adopted by the United Nations and the European Union to such extent such
                                            sanctions are extended by the UK Government to its Overseas Territories, as such lists may
                                            be amended from time to time; or (iv) a person who acts, directly or indirectly, for a senior
                                            foreign political figure, any member of a senior foreign political figure’s immediate
                                            family or any close associate of a senior foreign political figure, unless the Company, after
                                            being specifically notified by the Purchaser in writing that it is such a person, conducts
                                            further due diligence, and determines that the purchase is permitted. If Purchaser’s
                                            country of residence or other circumstances change such that the above representations are
                                            no longer accurate, the Purchaser will immediately notify the Company. To the knowledge of
                                            the Purchaser, (i) no person or entity that controls, is controlled by or under common control
                                            with, the Purchaser is a Prohibited Person, and (ii) no person having any direct or indirect
                                            beneficial interest in the Purchaser is a Prohibited Person.
	 	 	 
		14.	The
                                            Purchaser will not use the Tokens in connection with any activity that violates applicable
                                            laws in any relevant jurisdiction, including, but not limited to, use of the Tokens in connection
                                            with transactions that violate U.S. federal or state securities or commodity laws.
	 	 	 
		15.	By
                                            agreeing to this Agreement, the Purchaser consents to the disclosure by or on behalf of the
                                            Company of any information about the Purchaser to regulators and others upon request in connection
                                            with money laundering and similar matters, both in the British Virgin Islands and in other
                                            jurisdictions.
	 	 	 
		16.	The
                                            funds, including any fiat currency, virtual currency or other cryptographic token, that Purchaser
                                            uses to purchase Tokens are not derived from or related to any unlawful activities, including
                                            but not limited to money laundering or terrorist financing, and Purchaser will not use Tokens
                                            to finance, engage in, or otherwise support any unlawful activities. All payments by Purchaser
                                            under this Agreement will be made only in Purchaser’s name, from a digital wallet or
                                            bank account held in Purchaser’s name and under Purchaser’s control, and not
                                            located in a country or territory that has been designated as a “non-cooperative country
                                            or territory” by the Financial Action Task Force, and is not a “foreign shell
                                            bank” within the meaning of the U.S. Bank Secrecy Act (31 U.S.C. § 5311 et seq.),
                                            as amended, and the regulations promulgated thereunder by the Financial Crimes Enforcement
                                            Network, as such regulations may be amended from time to time.
	 	 	 
		17.	The
                                            Purchaser is responsible for implementing reasonable measures for securing Purchaser’s
                                            wallet, vault or other storage mechanism used to receive and hold Tokens purchased under
                                            this Agreement, including any requisite private key(s) or other credentials necessary to
                                            access such storage mechanism(s). If the private key(s) or other access credentials are lost,
                                            the Purchaser may lose access to the Tokens. The Company is not responsible for any such
                                            losses.

 

    	- 17 -

    	 

    

 

EXHIBIT
B

 

RISK
FACTORS

 

A
purchase of the Tokens involves a high degree of risk. You should carefully consider the risks and uncertainties described below before
deciding to purchase the Tokens. The occurrence of any of the following risks could result in you losing all or part of your Purchase
Amount.

 

Business
Risks

 

Risks
Associated to the Structure of Pre-Launch Token Sale Agreements

 

An
investment in a Pre-Launch Token Sale Agreement involves a significant amount of risk and is suitable only for sophisticated Purchasers:
(i) of substantial means who have no immediate need for liquidity in the amount invested; (ii) for whom such investment does not constitute
a complete investment program; (iii) that fully understand, and are willing to assume and have the financial resources necessary to withstand,
the risks involved in investing in a Pre-Launch Token Sale Agreement; and (iv) that can bear the potential loss of all of their investment
in a Pre-Launch Token Sale Agreement. There is no assurance as to whether an investment in a Pre-Launch Token Sale Agreement will be
profitable. Any Investment made in a Pre-Launch Token Sale Agreement may result in a loss of all or part of a Purchaser’s Investment.

 

This
investment is extremely risky and is not an appropriate investment for every Purchaser eligible to participate. The Company does not
warrant the offering’s suitability for any particular Purchaser. The Company is in the earliest stages of planning and developing
its products. Consequently, many details about the Company’s products, development strategy, and business model are not known,
are uncertain, and are subject to change, with or without notice to you. Each Purchaser should review these Risk Factors, the Pre-Launch
Token Sale Agreement and any other information provided to Purchasers as part of this offering (collectively, the “Offering
Materials”) carefully; however, many details in the Offering Materials may change, and in some circumstances, quite significantly.
Potential Purchasers should not participate in the offering unless they are able to bear a total and complete loss of their investment.
Purchasers should ask the Company questions about the offering and should not participate in the offering until they have received answers
that are satisfactory to them. Potential Purchasers should seek out independent accounting, financial, legal, and tax advice before participating
in the offering.

 

Until
a potential Purchaser’s Pre-Launch Token Sale Agreement has been accepted by the Company, potential Purchasers are under no obligation
to participate in the offering. Because the Tokens and Network are still in development, many of the terms associated with them may change,
and additional terms may apply. There is no guarantee that the Tokens or Network will develop as planned. Purchasers who are considering
executing a Pre-Launch Token Sale Agreement should not rely on the terms for the Tokens or the Network described in the Offering Materials
as being a promise or guarantee.

 

Risks
Related to Management

 

The
Company has little to no performance or operational record with cryptoassets, and the Company is in the earliest stages of planning and
developing its products. Consequently, many details about the Company’s products, development strategy, and business model are
not known, are uncertain, and are subject to change. By participating in the offering, Purchasers are relying completely on management
and key employees for the successful development and operation of the Tokens and Network.

 

    	- 18 -

    	 

    

 

In
addition, the Company operates at the conjunction of several highly competitive industries, including software development and cryptoassets,
and its ability to compete in these industries, and to scale its operations to the extent necessary, depends upon its ability to attract,
motivate, train, and retain highly qualified managerial and development personnel. Competition for skilled personnel is intense and the
turnover rate can be high, which may limit the Company’s ability to hire and retain highly qualified personnel on acceptable terms
or at all. The Company also anticipates that its employees will be employed on an at-will basis, which means that any of its employees
could leave its employment at any time, with or without notice. To induce valuable employees to remain at the Company, the Company may
opt to use Tokens as a form of compensation or bonus; however, the value of the Tokens may fluctuate significantly due to factors that
are within or beyond the Company’s control and which are described further in these Risk Factors. For these and other reasons,
valuable employees may leave the Company due to more lucrative offers from other companies. In addition, the Company does not maintain
“key man” insurance policies on the lives of its management or its other employees. The loss of the services of any of members
of its management or other key employees or the Company’s inability to find suitable replacements, or to recruit a sufficient number
of qualified personnel to scale its operations, due to the foregoing factors or any other factors, could result in delays in development
of the Network, harm the Network, and adversely affect the future value and utility of any Tokens Purchasers hold.

 

Risks
Relating to the Further Development and Acceptance of Blockchain Technology and Cryptographic Tokens

 

The
growth of the blockchain industry in general and cryptographic tokens in particular is subject to a high degree of uncertainty. The factors
affecting the foregoing include, without limitation:

 

●
Worldwide growth in the adoption and use of blockchain technologies and cryptographic tokens;

 

●
Government and quasi-government regulation of blockchain technologies and cryptographic tokens;

 

●
The availability and popularity of other forms or methods of buying and selling goods and services, or trading assets, including new
means of using fiat currencies;

 

●
General economic conditions; and

 

●
A decline in the popularity or acceptance of cryptographic tokens.

 

The
slowing or stopping of the development, general acceptance and adoption and usage of blockchain technologies and cryptographic tokens
may deter or delay the acceptance and adoption of the Network and the Tokens.

 

Risks
Associated with the Development and Launch of the Tokens

 

The
Tokens have not yet been developed and their development will require significant capital, the expertise of the Company’s management
and substantial time and effort by skilled developers and other parties. The Company may not retain the services of developers with the
technical skills and expertise needed to successfully develop the Tokens and progress the Tokens to a successful launch. In addition,
even if the Tokens are successfully developed and launched, there can be no assurance that the Tokens will function as intended or that
the Tokens will be useful long-term on the Application. Changes to the features and specifications of the Tokens and the Company’s
plans to distribute the Tokens (including the total Token supply, the initial circulating Token Supply and initial Token allocations
to various parties) may be made for any number of reasons. There can be no assurance that the Network will function as currently planned
or that the Tokens will be launched according to the Company’s current plans.

 

    	- 19 -

    	 

    

 

The
Company plans to incorporate various technology solutions into the Application at the same time it introduces the Tokens into the Network.
Some or all of these technology solutions may be new and/or relatively untested. There is significant risk to building and implementing
such new technologies that may have never been used, or that are being used in different ways. There is no guarantee that such technologies
will operate as intended or will be launched according to the Company’s current plans.

 

Additionally,
the Company may change its plans for issuing the Tokens for a variety of reasons, including a change in business plan, technological
challenges, lack of perceived demand, or other reasons. Finally, if the Company ceases operations, agrees to assign its assets and liabilities
to a third party for the benefit of creditors in the case of insolvency, or engages in a liquidation or winding up, it may never issue
the Tokens.

 

Risks
Associated with a Lack of Interest in the Tokens

 

It
is possible that the Tokens will not be used by a large number of individuals, companies and other entities and/or that there will be
limited public interest in the creation and development of blockchain-based products, services and ecosystems (such as the Application
or Tokens) more generally or applications to be used on or in connection with the Network, such as the Application. Such a lack of use
or interest could negatively affect the development and use of the Application and the potential utility of the Tokens.

 

Technical
Risks Associated with the Network

 

The
Network may include coding errors or otherwise not function as intended, which may negatively affect the Network generally, the Application
specifically, and the functionality of the Tokens. Upgrades to the Network after it launches, a hard fork in the Blockchain or a change
in how transactions are confirmed on the Blockchain may have unintended adverse effects on the Tokens. As a result, any such coding errors
or unintended functionalities in the Network and their corresponding effect on the Tokens may remain unresolved.

 

Risk
that Technology is Superseded or Replicated

 

There
can be no assurance that the Blockchain and related technology being proposed to underpin the use of the Tokens on the Network will not
be supplanted by competing protocols that improve upon, or fully replace, the Blockchain. It is not known whether the Blockchain on which
the Tokens are built will become the predominant protocol adopted globally by the industry. If the Blockchain is surpassed or superseded,
usage of the Tokens and adoption may decline. The source code on which the Token is based may be available as open-source, meaning that
anyone can copy and disseminate the Tokens’ source code either in the same form or with modifications as a “fork.”

 

Risk
of Competing Ecosystems

 

It
is possible that alternative ecosystems could be established that utilize the same open source code and protocol underlying the Blockchain
and attempt to facilitate services that are materially similar to those provided by the Blockchain. The Blockchain may compete with these
alternatives, which could negatively impact the Tokens, including the utility of the Tokens.

 

    	- 20 -

    	 

    

 

Risk
of Migration to New Blockchain and/or Token

 

It
is possible that the Company may in the future allow or require users of the Network to migrate their Tokens to another blockchain and/or
upgrade their Token into a new digital asset. The Company may choose to do so for numerous reasons, including, without limitation, to
address regulatory requirements, due to technological constraints, because of restrictions or failures arising from the existing blockchain,
to minimize transaction costs to users, or to enable the Company to incorporate new features into the Network. There can be no assurance
that the migration to a new blockchain will be successful or that the Token will retain the same features and functionality if the holder
chooses not to migrate their Token to the new blockchain.

 

Regulatory
and Legal Risks

 

Uncertain
Regulatory Framework

 

The
regulatory status of cryptographic tokens, digital assets and blockchain technology is unclear or unsettled in many jurisdictions. It
is difficult to predict how or whether governmental authorities will regulate such technologies. It is likewise difficult to predict
how or whether any governmental authority may make changes to existing laws, regulations and/or rules that will affect cryptographic
tokens, digital assets, blockchain technology and its applications. Such changes could negatively affect the Tokens in various ways,
including, for example, through a determination that the Tokens are regulated financial instruments that require registration or licensing
of those instrument or some or all of the parties involved in the sale, purchase and delivery thereof. The Company may cease the distribution
of Tokens, cease development in connection with the Network, cease use of the Network, or cease operations in a specific jurisdiction
in the event that governmental authority, regulatory actions, changes to law or regulations, or other actions make such distribution,
development and/or operations unlawful or commercially undesirable to obtain the necessary regulatory approval(s) to operate in such
jurisdiction.

 

Legal
and Regulatory Factors Relating to the Company’s Business Model Might Present Barriers to Success

 

The
Tokens will operate in a new and developing legal and regulatory environment. The established body of law, regulations, and court decisions
concerning blockchain technologies and smart contracts is nascent, and the law regarding cryptographic tokens is developing. As a result,
it is possible that there could be legal disputes over the interpretation of smart contracts used in connection with the Network or Tokens,
thus undermining the functionality of the Network and the Tokens. To the extent licenses or other authorizations are required in one
or more jurisdictions in which the Company operates or will operate, there is no guarantee that the Company will be granted such licenses
or authorizations. The Company may need to change its business model, and therefore modify the proposed use of the Network and the Tokens
to comply with these licensing and/or registration requirements (or any other legal or regulatory requirements) in order to avoid violating
applicable laws or regulations or because of the cost of such compliance.

 

    	- 21 -

    	 

    

 

Risks
of Government and Private Actions

 

The
market for cryptographic tokens and blockchain technologies is new, and may be subject to heightened oversight and scrutiny, including
investigations or enforcement actions. There can be no assurance that governmental authorities will not examine the operations of the
Company, or enact regulations or pursue enforcement actions against the Company, which may result in curtailment of, or inability to
operate, the Application or Tokens as intended, or judgments, settlements, fines or penalties against the Company. In addition, non-governmental
parties may bring private legal actions against the Company, either individually or as a class, which may result in curtailment of, or
inability to operate, the Application or Tokens as intended, or judgments, settlements, fines or penalties against the Company.

 

Risks
Associated with Intellectual Property Matters

 

The
Company does not currently hold any issued patents and, thus, would not be entitled to exclude or prevent other entities from replicating
its technology, methods and processes. While the Company enters into confidentiality and invention assignment agreements with its developers,
no assurance can be given that these agreements will be effective in controlling access to the Company’s proprietary information
and trade secrets. The confidentiality agreements on which the Company relies to protect certain technologies may be breached, may not
be adequate to protect its confidential information, trade secrets and proprietary technologies and may not provide an adequate remedy
in the event of unauthorized use or disclosure of its confidential information, trade secrets or proprietary technology. Further, these
agreements do not prevent the Company’s competitors or others from independently developing technology that is substantially equivalent
or superior to their technology. In addition, others may independently discover the Company’s trade secrets and confidential information,
and in such cases, the Company likely would not be able to assert any trade secret rights against such parties.

 

Although
the Company does not believe that the technology, processes and methods relating to the Application or Tokens have been patented by any
third party, it is possible that patents have been issued to third parties that cover all or a portion of the Application or Tokens.
Patent holders or other intellectual property owners may assert that the Company’s methods or practices infringe, misappropriate
or otherwise violate their intellectual property or other proprietary rights. Any such claims, regardless of merit, could result in substantial
expenses, divert the attention of management or materially disrupt the operation of the Application or Tokens, including through awarded
injunctive relief.

 

Other
Risks

 

Risks
of Losing Access to the Tokens

 

When
delivered, the Tokens received by you may be held in a digital wallet or vault, which requires a private key or a combination of private
keys for access. Accordingly, loss of the private key(s) associated with your digital wallet or vault storing the Tokens will result
in the loss of such Tokens. Moreover, any third party that gains access to such private key(s), including by gaining access to login
credentials of a hosted wallet or vault service you use, may be able to misappropriate your Tokens. The Company is not responsible for
any such losses.

 

In
addition, any errors or malfunctions caused by or otherwise related to the digital wallet or vault you choose to receive and store Tokens,
including your own failure to properly maintain or use such digital wallet or vault, may also result in the loss of your Tokens. Additionally,
your failure to follow precisely the procedures set forth for buying and receiving Tokens, may also result in the loss of your Tokens.

 

    	- 22 -

    	 

    

 

Risks
Associated with the Blockchain Protocol

 

Because
the Tokens and the Network are based on the Blockchain’s protocol, any malfunction, breakdown or abandonment of the Blockchain
protocol may have a material adverse effect on the Tokens or the Network. Moreover, advances in cryptography, or technical advances such
as the development of quantum computing, could present risks to the Tokens and the Network, including the utility of the Tokens, by rendering
ineffective the cryptographic consensus mechanism that underpins the Blockchain’s protocol.

 

Risks
of Hacking and Security Weakness

 

The
Tokens may be subject to expropriation and/or theft. Hackers or other malicious groups or organizations may attempt to interfere with
the Network or with the Tokens in a variety of ways, including but not limited to malware attacks, denial of service attacks, consensus-based
attacks, Sybil attacks, smurfing and spoofing. Furthermore, because the Tokens may be released as open-source software, hackers or other
individuals may uncover and exploit intentional or unintentional bugs or weaknesses in Tokens which may negatively affect the Network
and the Tokens, including the utility of the Tokens. Hackers or other malicious groups of organizations may also attempt to get access
to private keys or other access credentials of any wallet, vault, or other storage mechanism used to receive and hold the Tokens which
would result in the loss of your Tokens or the loss of your ability to access or control your Tokens.

 

Risks
of Uninsured Losses

 

Unlike
bank accounts or accounts at some other financial institutions, the Tokens are uninsured unless you specifically obtain private insurance
to insure them. Thus, in the event of loss or loss of utility value, there is no public insurer, such as the Federal Deposit Insurance
Corporation, or private insurance arranged by the Company, to offer recourse to you.

 

Risks
Associated with The Sale and Purchase of the Tokens

 

The
Tokens are intended to be used by users of the Application. The Tokens are not investment products. There should be no expectation of
future profit or gain from the purchase or sale of the Tokens. The Tokens do not represent (i) any equity or other ownership interest
in the Company, (ii) any rights to dividends or other distribution rights from the Company, or (iii) any governance rights in the Company
or Tokens.

 

Public
policy towards selling cryptographic tokens is evolving, and it is conceivable that regulators may in the future seek to broaden the
scope of regulation applicable to the sale of cryptographic tokens. If the offer and sale of the Tokens becomes subject to registration,
prospectus or licensing requirements in a particular jurisdiction, the Company may be found liable if it has not complied with the applicable
registration, prospectus or licensing requirements, and the market for the Tokens may be adversely affected. There are also other risks
of participating in any purchase of cryptographic tokens, including volatility in cryptographic token markets, the possibility of increasing
regulation of cryptographic token exchange, the potential for a post facto government investigation of a sale of cryptographic tokens,
among other risks.

 

Risk
of Price Volatility

 

The
prices of cryptographic tokens have historically been subject to dramatic fluctuations and are highly volatile, and the market price
of the Tokens may also be highly volatile. Several factors may influence the market price of the Tokens, including, but not limited to:

 

●
Global supply of cryptographic tokens, both with respect to the number of different cryptographic tokens and the supply of each individual
cryptographic token;

 

    	- 23 -

    	 

    

 

●
Global demand for cryptographic tokens, which can be influenced by the growth of acceptance of cryptographic tokens as payment for goods
and services, the security of online cryptographic token exchanges and digital wallets that hold cryptographic tokens, the perception
that the use and holding of cryptographic tokens is safe and secure, and the regulatory restrictions on their use;

 

●
Changes in software, software requirements or hardware requirements underlying blockchain technologies;

 

●
Fiat currency withdrawal and deposit policies of cryptographic token exchanges on which cryptographic tokens may be traded and liquidity
on such exchanges;

 

●
Interruptions in service from or failures of major cryptographic token exchanges;

 

●
Investment and trading activities of large investors, including private and registered funds, that may directly or indirectly invest
in cryptographic tokens;

 

●
Monetary policies of governments, trade restrictions, currency devaluations and revaluations; and

 

●
Regulatory measures, if any, that affect the use of cryptographic tokens.

 

A
decrease in the price of a single cryptographic token may cause volatility in the entire cryptographic token industry and may affect
other cryptographic tokens, including the Tokens. For example, a security breach that affects investor or user confidence in Bitcoin
or Ethereum may affect the industry as a whole and may also cause the price of the Tokens and other cryptographic tokens to fluctuate.

 

The
volatility and unpredictability of the price of cryptoassets, including the Tokens, relative to fiat and other currency may result in
significant loss over a short period of time. In addition, the value of the Tokens may be derived from the continued willingness of market
participants to exchange fiat and other currency for the Tokens, which may result in the potential for permanent and total loss of value
of the Tokens should the market for them disappear.

 

In
the absence of such pricing, the price of the Tokens may be limited to what a buyer is willing to pay in a privately negotiated, arms-length
transaction. The Company is under no obligation to provide any Token valuations to Purchasers.

 

Risks
Associated with the Use of Proceeds

 

There
is no restriction on the Company’s use of the proceeds paid by the Purchaser except as set forth in the Agreement and there is
no restriction on the Company’s ability to transfer those funds to, or make payments for the benefit of, its affiliates, including
as compensation to the Company’s directors, officers and employees. There can be no assurance that the Company will have sufficient
funds to make repayment of any Refund Amount (as defined in the Agreement) as and when required under the terms of the Agreement.

 

    	- 24 -

    	 

    

 

Taxation
Risks

 

The
tax characterization of the Tokens is uncertain, and you must seek your own tax advice in all jurisdictions relevant to you in connection
with your purchase of the Tokens. A purchase of the Tokens may result in adverse tax consequences to you, including withholding taxes,
income taxes and tax reporting requirements. It is also possible that the proceeds to the Company would be subject to significant amounts
of income and/or withholding taxes. Further, the use of the Tokens as a form of currency may or may not be subject to income taxes, capital
gains taxes, value added, sales or use taxes or other forms of taxes. The uncertainty in the tax treatment of the Tokens and transactions
in the Tokens may expose subscribers, prospective purchasers and the Company alike to unforeseen future tax consequences associated with
the purchase, ownership, sale or other use of the Tokens.

 

Capital
Control Risks

 

Many
jurisdictions impose strict controls on the cross-border flow of capital. Holders of the Tokens may be subject to these regulations.

 

Countering
the Financing of Terrorism (“CFT”) and Anti-Money Laundering (“AML”) Regulations

 

Many
countries have implemented laws and regulations to combat terrorist financing and money- laundering activities, including laws and regulations
directed at controlling the flow of capital for such illicit activities. In the event that licenses, registrations or other authorizations
are required under applicable CFT and/or AML regulations to operate or use the Network or Tokens, there is no guarantee that the Company
will be able to successfully obtain such licenses, registrations or authorizations. In addition, any illicit use of the Tokens by bad
actors could breach such regulations and seriously impact the global reputation of the Network or Tokens. In such event, it is conceivable
that this could trigger scrutiny by CFT and AML regulators and potentially cause significant disruption to the distribution and circulation
of the Tokens.

 

Unanticipated
Risks

 

Cryptographic
tokens such as the Tokens are a new and untested technology. In addition to the risks included herein there are potentially other unanticipated
risks associated with the purchase, possession, and use of the Tokens. Such risks may further materialize as unanticipated variations
or combinations of the risks discussed herein.

 

    	- 25 -

    	 

    

 

EXHIBIT
C

 

ANTI-MONEY
LAUNDERING & COUNTER FINANCING OF TERRORISM (“AML/CFT”) 

ADDITIONAL
REPRESENTATIONS & WARRANTIES FOR NON-U.S. PURCHASERS

 

The
Purchaser accepts, agrees with, undertakes, represents and warrants to the Company, (with the intent that the provisions of this clause
shall continue to have full force and effect until the termination of this Agreement) as follows:

 

		1.	Verification
                                            of Identity. That the Purchaser acknowledges that, in order to comply with measures
                                            aimed at the prevention of money laundering and terrorism financing, the Company and/or any
                                            of its delegates or agents, may require verification of the identity of the Purchaser and
                                            the source of the Purchaser’s purchase monies. The Purchaser undertakes to provide:
                                            (i) such information and documentation as the Company and/or any of its delegates or agents
                                            may request to verify any information about the Purchaser in compliance with applicable anti-money
                                            laundering laws and regulations; and (ii) any further information and documentation as the
                                            Company and/or any of its delegates or agents may request from time to time to ensure ongoing
                                            compliance with applicable laws and regulations, or any other related policies, best practice
                                            guidelines and regulations as implemented by the Company at its sole discretion, from time
                                            to time. The Purchaser acknowledges that, apart from distribution of any Refund Amount, as
                                            applicable, neither the Company nor any of its delegates or agents shall be liable for any
                                            loss arising as a result of a failure to distribute Tokens to the Purchaser if such information
                                            and documentation as has been requested has not been provided by the Purchaser.
	 	 	 
		2.	Prohibited
                                            Purchasers. That the Purchaser understands and agrees that the Company prohibits
                                            the purchase of the Pre-Launch Token Sale Agreement (the “Agreement”)
                                            by any persons or entities that are acting, whether directly or indirectly: (i) in contravention
                                            of any U.S., other national, international or other money laundering regulations or conventions;
                                            or (ii) on behalf of terrorists, terrorist organizations or other high-risk entities, including
                                            those persons or entities that are included on any relevant lists maintained by the United
                                            Nations, North Atlantic Treaty Organization, Organization for Economic Cooperation and Development,
                                            Financial Action Task Force, U.S. Office of Foreign Assets Control, U.S. Securities &
                                            Exchange Commission, U.S. Federal Bureau of Investigation, U.S. Central Intelligence Agency,
                                            U.S. Internal Revenue Service, Financial Crimes Enforcement Network (“FinCEN”),
                                            the Office of Foreign Assets Control (“OFAC”), countries listed by Transparency
                                            International (www.transparency.org) as being vulnerable to corruption, or any country or
                                            organization, all as may be amended from time to time; (iii) for a senior foreign political
                                            figure, any member of a senior foreign political figure’s immediate family or any close
                                            associate of a senior foreign political figures; or (iv) for a foreign shell bank (each of
                                            (i) to (iv) a “Prohibited Purchaser”), in each case unless the Company,
                                            after being specifically notified by the Purchaser in writing that the Purchaser may be a
                                            Prohibited Purchaser, conducts further enhanced due diligence, and performs appropriate verification
                                            checks on the Purchaser to ensure their legitimacy and reliability, and determines that such
                                            investment shall be permitted;
	 	 	 
		3.	Purchaser
                                            is Not a Prohibited Purchaser. That the Purchaser is not a Prohibited Purchaser,
                                            that the Purchaser is not a Prohibited Purchaser in any future purchase of this Agreement,
                                            and that the Purchaser will promptly notify the Company of any change in its status or the
                                            status of any ultimate beneficial owners for whom the Purchaser is purchasing the Agreement
                                            on behalf of;

 

    	- 26 -

    	 

    

 

		4.	Timely
                                            and Accurate Submission of Information. That any information submitted by the Purchaser
                                            to the Company for the conduct of AML/CFT checks shall be within the Company’s requested
                                            time frame, up to date, complete, truthful, and accurate as of the date of this Agreement,
                                            and shall continue to be so at any time that the Purchaser holds the Agreement;
	 	 	 
		5.	Termination.
                                            That in the event the Company determines, at its sole discretion, that any Purchaser is a
                                            Prohibited Purchaser, it may, without further reference to the Purchaser, take any action
                                            necessary to terminate the interests of the Purchaser in the Agreement under the terms of
                                            the Agreement, and the Purchaser shall have no claim against the Company for any form of
                                            damages whatsoever as a result of the same except as set forth in the Agreement;
	 	 	 
		6.	Law
                                            Enforcement Compliance. That the Company may release confidential information about
                                            the Purchaser and, if applicable and to the extent necessary, any ultimate beneficial owner(s)
                                            of the Agreement to any proper authorities in any jurisdiction, if the Company, in its sole
                                            discretion, determines that it is in the best interests of the Company in light of relevant
                                            rules and regulations concerning Prohibited Purchasers, money-laundering, terrorism financing,
                                            or any other illicit purpose;
	 	 	 
		7.	Lawfully
                                            Acquired Currency. That the Purchaser only uses fiat currency or digital currencies
                                            as lawfully acquired, to make payment for the Agreement, that such currency is not derived
                                            from or related to any unlawful activities conducted by Purchaser, including but not limited
                                            to money laundering or terrorist financing, and that the Purchaser does not acquire the Agreement
                                            to finance, engage in, or otherwise support any money-laundering, terrorism financing or
                                            other illicit purpose;
	 	 	 
		8.	Beneficial
                                            Owners. That to the extent that the Purchaser has any beneficial owners, the Purchaser
                                            reasonably believes that no beneficial owner is a Prohibited Purchaser;
	 	 	 
		9.	Sanctions.
                                            That neither the Purchaser, nor to the knowledge of the Purchaser any person having a direct
                                            or indirect beneficial interest in Purchaser or the Agreement being acquired by Purchaser,
                                            or any person for whom Purchaser is acting as agent or nominee in connection with the Agreement,
                                            is the subject of sanctions administered or enforced by any country or government (collectively,
                                            “Sanctions”) or is organized or resident in a country or territory that
                                            is the subject of country-wide or territory-wide Sanctions;
	 	 	 
		10.	AML
                                            Compliance. That the Purchaser is in full compliance with all anti-money laundering
                                            laws and regulations that are in force, and the purchase of Tokens under the Agreement by
                                            the Purchaser will not be in breach of any laws and regulations that are in force in any
                                            relevant jurisdiction;
	 	 	 
		11.	Truthful
                                            and Accurate Information. That the Purchaser, in knowledge that the Company may be
                                            relying upon its submissions acknowledgements, representations and statements contained therein
                                            without performing further verification, will completely, truthfully, and accurately comply
                                            with, perform any action, and fulfill any instructions and requests from the Company in order
                                            for the Company to comply with any anti-money laundering or customer due diligence policies,
                                            best practice guidelines and regulations as implemented by the Company at its sole discretion,
                                            from time to time;
	 	 	 
		12.	Sufficiency
                                            of Evidence. If any of the representations, warranties or covenants above cease to
                                            be true or if the Company and/or its delegates or agents no longer reasonably believes that
                                            it has satisfactory evidence as to their truth, notwithstanding any other agreement to the
                                            contrary, the Company and/or its delegates or agents may, in accordance with applicable regulations,
                                            be obligated to: (i) take certain actions relating to the Purchaser’s holding of Agreement;
                                            (ii) report such action; and (iii) disclose the Purchaser’s identity to OFAC or other
                                            authority. In the event that the Company and/or its delegates or agents is required to take
                                            any such action, the Purchaser understands and agrees that it shall have no claim against
                                            the Company and/or its delegates or agents for any form of damages as a result of any of
                                            such actions; and
	 	 	 
		13.	Mandatory
                                            Reporting. The Purchaser acknowledges and understands that if, as a result of any
                                            information or other matter which comes to his attention, any person, knows or suspects or
                                            has reasonable grounds for knowing or suspecting that another person is engaged in criminal
                                            conduct or is involved with terrorism or terrorist property and the information for that
                                            knowledge or suspicion came to their attention in the course of business in the regulated
                                            sector, or other trade, profession, business or employment, the person will be required to
                                            report such knowledge or suspicion to the relevant governmental authorities.

 

    	- 27 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]